butylscopolammonium bromide has been researched along with camylofine in 1 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (camylofine) | Trials (camylofine) | Recent Studies (post-2010) (camylofine) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 32 | 1 | 10 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | camylofine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 9.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SIELAFF, HJ | 1 |
1 other study(ies) available for butylscopolammonium bromide and camylofine
| Article | Year |
|---|---|
[Comparative experimental studies on the effect of spasmolytics and ganglion-blocking substances (atropin, avacan, pendiomid, buscopan, banthine) on motility of the human small intestine].
Topics: Atropine; Autonomic Agents; Butylscopolammonium Bromide; Glycine; Humans; Intestine, Small; Intestines; Methantheline; Muscle Relaxants, Central; Parasympatholytics; Quaternary Ammonium Compounds | 1953 |